Katharina Effenberger-Neidnicht Selected Research

Katharina Effenberger-Neidnicht Research Topics

Disease

8	Hemolysis 10/2019 - 12/2014
7	Inflammation (Inflammations) 04/2019 - 12/2014
6	Neoplasms (Cancer) 01/2012 - 09/2010
5	Sepsis (Septicemia) 10/2019 - 12/2014
3	Disseminated Intravascular Coagulation 10/2019 - 03/2016
3	Hypoglycemia (Reactive Hypoglycemia) 04/2019 - 10/2017
3	Endotoxemia 10/2017 - 06/2014
3	Melanoma (Melanoma, Malignant) 01/2012 - 03/2011
3	Breast Neoplasms (Breast Cancer) 01/2012 - 04/2011
2	Acidosis 04/2019 - 10/2017
2	Shock 04/2019 - 01/2019
2	Reperfusion Injury 04/2019 - 12/2014
2	Hemorrhagic Shock 04/2019 - 01/2019
2	Thrombocytopenia (Thrombopenia) 10/2017 - 03/2016
1	Hypothermia 01/2019
1	Wounds and Injuries (Trauma) 01/2019
1	Transfusion Reaction 10/2018
1	Hypertension (High Blood Pressure) 01/2018
1	Hyperkalemia 01/2018
1	Hyperglycemia 01/2018
1	Hypernatremia 01/2018
1	Tachycardia (Tachyarrhythmias) 01/2018
1	Hypocalcemia 01/2018
1	Drug Overdose 01/2018
1	Hypotension (Low Blood Pressure) 10/2017
1	Infections 12/2014
1	Hemorrhage 12/2014
1	Colonic Neoplasms (Colon Cancer) 09/2011
1	Leukemia 09/2011
1	Cardiotoxicity 04/2011
1	Carcinoma (Carcinomatosis) 03/2011

Drug/Important Bio-Agent (IBA)

11	LipopolysaccharidesIBA 10/2019 - 06/2014
4	Hemoglobins (Hemoglobin)IBA 10/2019 - 12/2014
4	Glucose (Dextrose)FDA LinkGeneric 04/2019 - 10/2017
4	Lactic Acid (Lactate)FDA LinkGeneric 04/2019 - 12/2014
4	AcidsIBA 04/2019 - 09/2011
4	Transaminases (Aminotransferases)IBA 04/2019 - 12/2014
4	ElectrolytesIBA 04/2019 - 12/2014
4	MelatoninIBA 10/2017 - 06/2014
2	Hemostatics (Antihemorrhagics)IBA 04/2019 - 10/2017
2	trioctyl phosphine oxide (TOPO)IBA 01/2012 - 09/2011
2	Pharmaceutical PreparationsIBA 01/2012 - 04/2011
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2012 - 04/2011
2	thymoquinoneIBA 04/2011 - 09/2010
1	Eptifibatide (Integrilin)FDA Link 10/2019
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 10/2019
1	argatroban (MPQA)FDA Link 10/2019
1	Thrombin FDA Link 10/2019
1	ChloridesIBA 04/2019
1	AnionsIBA 04/2019
1	Pyruvic Acid (Pyruvate)IBA 04/2019
1	SodiumIBA 04/2019
1	Ringer's SolutionIBA 01/2019
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2018
1	Therapeutic UsesIBA 01/2018
1	Cholinergic Antagonists (Anticholinergics)IBA 01/2018
1	PhysostigmineIBA 01/2018
1	Toll-Like Receptors (Toll-Like Receptor)IBA 10/2016
1	Complement System Proteins (Complement)IBA 10/2016
1	Dacarbazine (DIC)FDA LinkGeneric 03/2016
1	Peroxidase (Myeloperoxidase)IBA 12/2014
1	Hematoxylin (Haematoxylon)IBA 12/2014
1	Eosine Yellowish-(YS) (Eosin)IBA 12/2014
1	GasesIBA 12/2014
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 12/2014
1	Interleukin-10 (Interleukin 10)IBA 06/2014
1	Interferon-gamma (Interferon, gamma)IBA 06/2014
1	InterleukinsIBA 06/2014
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2014
1	Interleukin-5 (Interleukin 5)IBA 06/2014
1	Interleukin-6 (Interleukin 6)IBA 06/2014
1	CytokinesIBA 06/2014
1	LipidsIBA 01/2012
1	margaric acid (heptadecanoic acid)IBA 01/2012
1	ruthenoceneIBA 09/2011
1	illudin MIBA 09/2011
1	JNK Mitogen-Activated Protein KinasesIBA 09/2011
1	Cytotoxins (Cytolysins)IBA 09/2011
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 09/2011
1	LactonesIBA 09/2011
1	Volatile Oils (Essential Oils)IBA 04/2011
1	AndrogensIBA 03/2011
1	SteroidsIBA 03/2011
1	MetalsIBA 03/2011
1	DNA (Deoxyribonucleic Acid)IBA 03/2011
1	Estrogens (Estrogen)FDA Link 03/2011
1	Hormones (Hormone)IBA 03/2011
1	4-cymene (p-cymene)IBA 03/2011
1	Estrogen ReceptorsIBA 03/2011
1	Sex Hormone-Binding GlobulinIBA 03/2011
1	Ether (Diethyl Ether)IBA 02/2011
1	catechol (pyrocatechol)IBA 02/2011
1	SiderophoresIBA 02/2011
1	thespesoneIBA 09/2010
1	quinone (benzoquinone)IBA 09/2010

Therapy/Procedure

1	Rewarming 01/2019
1	Therapeutics 10/2017
1	Drug Therapy (Chemotherapy) 04/2011